INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 5 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,853,000 | -25.2% | 75,000 | +275.0% | 0.38% | -23.5% |
| Q4 2019 | $2,478,000 | -12.1% | 20,000 | -52.9% | 0.50% | -61.6% |
| Q3 2019 | $2,820,000 | -54.6% | 42,500 | -45.5% | 1.31% | -3.3% |
| Q2 2019 | $6,206,000 | +131.2% | 78,000 | +225.0% | 1.35% | +78.6% |
| Q1 2019 | $2,684,000 | – | 24,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caligan Partners LP | 1,200,000 | $22,248,000 | 10.22% |
| GROUP ONE TRADING, L.P. | 24,800 | $459,792 | 0.00% |
| SIMPLEX TRADING, LLC | 53,200 | $986 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 68,500 | $1,269,990 | 0.00% |